Citation Impact

Citing Papers

Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice
2005 StandoutScience
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
2004
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Long-term cigarette smoke exposure increases uncoupling protein expression but reduces energy intake
2008
Medicinal strategies in the treatment of obesity
2000 Nature
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
2013
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Reduction in Incidence of Diabetes, Hypertension and Lipid Disturbances after Intentional Weight Loss Induced by Bariatric Surgery: the SOS Intervention Study
1999
Effects of obesity on QT, RR, and QTc intervals
1995
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Novel Polymorphisms of Nuclear Receptor SHP Associated with Functional and Structural Changes
2010
QT Dispersion in Uncomplicated Human Obesity
2001
Progress and challenges in anti-obesity pharmacotherapy
2017
A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease
2005
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
2013 Standout
Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease
2006
Central nervous system control of food intake and body weight
2006 StandoutNature
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalisation of blood pressure
2004
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
1999
A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patients
2004
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
2022
Plasma transforming growth factor‐β1 level and efficacy of α‐tocopherol in patients with non‐alcoholic steatohepatitis: a pilot study
2001
The metabolic syndrome
2010 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
A Risk-Benefit Assessment of Anti-Obesity Drugs
1999
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: A dose-ranging study
1998
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
2004 Standout
Sequencing of the putative promoter region of the cocaine- and amphetamine-regulated-transcript gene and identification of polymorphic sites associated with obesity
2002
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
2002 Standout
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Benefits of lifestyle modification in NAFLD
2007
Treatment of obesity: need to focus on high risk abdominally obese patients
2001
Laparoscopic Swedish Adjustable Gastric Banding: 6-year Follow-up and Comparison to other Laparoscopic Bariatric Procedures
2003
Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society
2005
Autonomic dysfunction associates with prolongation of QT intervals and blunted night BP in obese women with visceral obesity
2002
The Human Obesity Gene Map: The 1997 Update
1998
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
A Pilot Study of A Thiazolidinedione, Troglitazone, in Nonalcoholic Steatohepatitis
2001
Is weight reduction an effective therapy for nonalcoholic fatty liver?
2003
Five Years of GWAS Discovery
2012 Standout
One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Nonalcoholic Steatohepatitis: A Pilot Study
2005
Obesity and the Risk for Cardiovascular Disease
2003
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
2006 Standout
Impact of bariatric surgery on cardiac structure, function and clinical manifestations in morbid obesity
2004
Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot Study
1996
The metabolic syndrome
2005 Standout
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
2006
Current status of medical and surgical therapy for obesity
2001
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
2001
Central nervous system control of food intake
2000 StandoutNature
Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis
2006
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Inflammatory Bowel Disease
2002 Standout
Physical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD
2011
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
2015
The Molecular Genetics of Rodent Single Gene Obesities
1997
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Surgery for morbid obesity
2005
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Obesity and Cardiovascular Disease
2009 Standout
Blood Pressure and Pulse Pressure during Long‐Term Weight Loss in the Obese: The Swedish Obese Subjects (SOS) Intervention Study
2001
Pitfalls of homozygosity mapping: an extended consanguineous Bardet–Biedl syndrome family with two mutant genes (BBS2, BBS10), three mutations, but no triallelism
2006
THE ENDOCRINOLOGY OF OBESITY
1996
Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials
2014
Gastric Surgery for Morbid Obesity
1990
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It
2006
Surgical Intervention as a Strategy for Treatment of Obesity
2000
Sudden cardiac arrest in morbidly obese surgical patients unexplained after autopsy
1988
Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis
2009
What We Talk About When We Talk About Fat
2014 Standout
A Core Complex of BBS Proteins Cooperates with the GTPase Rab8 to Promote Ciliary Membrane Biogenesis
2007 Standout
Effects of a Stimulant-Free Dietary Supplement on Body Weight and Fat Loss in Obese Adults: A Six-Week Exploratory Study
2003
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
1998 StandoutNature
Obesity and the Regulation of Energy Balance
2001 Standout
Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
2015
High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis
2010
Measuring Outcomes following Bariatric Surgery: Weight Loss Parameters, Improvement in Co-morbid Conditions, Change in Quality of Life and Patient Satisfaction
2003
Leptin and the regulation of body weight in mammals
1998 StandoutNature
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease
2005
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
2009
AGA technical review on obesity
2002
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Hepatocellular Carcinoma
2011 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Mitochondrial uncoupling as a target for drug development for the treatment of obesity
2001
Decreased bioavailability of vitamin D in obesity
2000 Standout
A Comparison of Valproate with Carbamazepine for the Treatment of Complex Partial Seizures and Secondarily Generalized Tonic–Clonic Seizures in Adults
1992
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients
2006
Weight change and blood coagulability and fibrinolysis in healthy obese women
2001
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21
2015 StandoutNobel
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Results of Obesity Surgery
1987
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
The natural history of nonalcoholic fatty liver: A follow-up study
1995
Assessment of quality of life before and after surgery for severe obesity
1992
Pharmacological and surgical treatment of obesity.
2004
Effects of Identical Weight Loss on Body Composition and Features of Insulin Resistance in Obese Women With High and Low Liver Fat Content
2003
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
2000
Genetics of obesity
2006
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
Treatment of Mild to Moderate Obesity with Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program
2006
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
The Control of Diabetes Mellitus (NIDDM) in the Morbidly Obese with the Greenville Gastric Bypass
1987
Genomics, Type 2 Diabetes, and Obesity
2010
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
A Double-Blind Randomized Placebo-Controlled Trial of Orlistat for the Treatment of Nonalcoholic Fatty Liver Disease
2006
Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease
2004
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Differentiated Long-Term Effects of Intentional Weight Loss on Diabetes and Hypertension
2000
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
1995
A Randomized Prospective Trial of Gastric Bypass Versus Vertical Banded Gastroplasty for Morbid Obesity and their Effects on Sweets Versus Non-Sweets Eaters
1987
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
2015
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Long-term Outcome of Bariatric Surgery: An Interim Analysis
2006
Effect of Weight Loss on Liver Free Fatty Acid Uptake and Hepatic Insulin Resistance
2008

Works of Teis Andersen being referenced

Amino Acid Variants in the Human Leptin Receptor: Lack of Association to Juvenile Onset Obesity
1997
Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction
1993
Hepatic effects of dietary weight loss in morbidly obese subjects
1991
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
1998
Mutation analysis ofNR0B2among 1545 Danish men identifies a novel c.278G>A (p.G93D) variant with reduced functional activity
2004
Sequence Variants in the Human Cocaine and Amphetamine‐Regulated Transcript (CART) Gene in Subjects with Early Onset Obesity
1999
Prevalence of Mutations and Functional Analyses of Melanocortin 4 Receptor Variants Identified among 750 Men with Juvenile-Onset Obesity
2005
Body Mass, Fat-Free Body Mass, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease from a Random Population Sample
2005
Weight gain during treatment with valproate
2009
The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone
1994
The Relationship between QTc Changes and Nutrition during Weight Loss after Gastroplasty
1985
Variation of the McKusick-Kaufman Gene and Studies of Relationships with Common Forms of Obesity
2005
Randomized Trial of Diet and Gastroplasty Compared with Diet Alone in Morbid Obesity
1984
Lack of adrenal gland suppression with budesonide enema in active distal ulcerative colitis
1994
Rankless by CCL
2026